{"Related drugs": {"malignant melanoma": ["Intron A", "Sylatron", "Opdivo", "Temodar", "interferon alfa-2b", "Yervoy", "Proleukin", "Keytruda", "PegIntron", "DTIC-Dome", "ipilimumab", "nivolumab", "temozolomide", "dacarbazine", "pembrolizumab", "aldesleukin", "peginterferon alfa-2b", "Imlygic", "talimogene laherparepvec"], "melanoma metastatic": ["Yervoy", "ipilimumab", "Temodar", "Tafinlar", "Zelboraf", "vemurafenib", "temozolomide", "dabrafenib", "Mekinist", "Sotret", "trametinib", "Keytruda", "Claravis", "isotretinoin", "Amnesteem", "Myorisan", "PegIntron", "Sylatron", "pembrolizumab", "nivolumab", "Opdivo", "peginterferon alfa-2b", "Cotellic", "aldesleukin", "cobimetinib", "Imlygic", "Proleukin", "talimogene laherparepvec"]}, "Generic Name": "peginterferon alfa-2b", "Drug Name": "Sylatron (Subcutaneous)", "Side Effects": {"Major": {"More common:": ["Abdominal or stomach pain", "anxiety", "black, tarry stools", "blood in the urine or stools", "bloody diarrhea", "chills", "cloudy urine", "cough or hoarseness", "depression", "difficult or labored breathing", "fever", "irritability", "lower back or side pain", "mood swings", "nausea", "painful or difficult urination", "pale skin", "pinpoint red spots on the skin", "tightness in the chest", "trouble sleeping", "troubled breathing with exertion", "unusual bleeding or bruising", "unusual tiredness or weakness", "vomiting"]}}, "Interactions": {}}